Joshi Rohit - Faculty of Health and Medical Sciences, The University of Adelaide

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 36 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Impact of Combined Chemotherapy and Intra-Tumoural Injection of Phosphorus-32 Microparticles on Vascularity in Locally Advanced Pancreatic Carcinoma

Amanda Huoy Wen Lim,Joshua Zobel, Madison Bills,William Hsieh,Benjamin Crouch,Rohit Joshi, John-Edwin Thomson, EuLing Neo, Li Lian Kuan,Romina Safaeian,Edmund Tse, Christopher K Rayner,Andrew Ruszkiewicz,Nimit Singhal,Dylan Bartholomeusz,Nam Quoc Nguyen

Cancersno. 19 (2024)

引用0浏览0WOS引用

Phase IB/II First Line Panitumumab, Irinotecan, Trifluridine/tipiracil in RAS Wild-Type Patients with Metastatic Colorectal Cancer: PIT Study

Timothy Jay Price,Rohit Joshi, Christos Stelios Karapetis, Pam Cooper, Chris Hocking,Nimit Singhal,Amanda Rose Townsend

Journal of Clinical Oncologyno. 16_suppl (2024): e15532-e15532

引用0浏览0引用

599 Single-agent safety and activities of target-preserving anti-CTLA-4 antibody gotistobart (ONC-392/BNT316) in PD-(L)1 resistant metastatic NSCLC and population PK analysis in patients with solid tumors

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

Safety and Clinical Activity of Target-Preserving Anti-Ctla-4 Antibody ONC-392 As Monotherapy in NSCLC Patients Who Progressed on PD(L)1-targeted Immunotherapy

Kai He,David Paul Carbone,Meredith McKean,Rama Balaraman,Satish Shah,Edward Arrowsmith,Julio Antonio Peguero,Rohit Joshi,Aiwu Ruth He, Adriana Milillo,John Turner Hamm,Mark Gregory Goldstein,Zihai Li,Yang Liu,Pan Zheng,Tianhong Li

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC)

Melissa Lynne Johnson, William Fox,Yun-Gyoo Lee,Ki Hyeong Lee,Hee Kyung Ahn,Young-Chul Kim,Kang-Yun Lee,Jong-Seok Lee, Xian He, Christine Park, Debbie Pomponio, Thao Dang,Patrick Hoang Phuong,Dimitry S. A. Nuyten,Aparna Madhukeshwar Hegde,Rohit Joshi

Journal of Clinical Oncologyno. 36_suppl (2022): 397600-397600

引用0浏览0引用

A Prospective Audit of Inpatient Medical Oncology Consultation Patterns in A Tertiary Teaching Hospital in South Australia

Rohit Joshi,Siobhan O'Neill,Dorothy Keefe

Global journal of epidemiology and public healthno. 2 (2022): 42-47

引用22浏览0引用

A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trial

Xiomara Skrabal Ross,Kate M Gunn,Vijayaprakash Suppiah,Pandora Patterson,Terry Boyle,Christine Carrington,Shir Ley Tan,Marissa Ryan,Rohit Joshi,Ian Olver

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2022）

引用0浏览0WOS引用

Real-world comparative data on addition of Atezolizumab to platinum-doublet chemotherapy in extensive stage small cell lung cancer - A single South Australian institution experience

Yao J. Ly,Christopher Hocking,Rohit Joshi,Dainik Patel, Hooi Hong,Mark McGregor,Annabel Smith,Vineet Kwatra

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)

引用0浏览0引用

CSCO Breast Cancer Management Guidelines 2022: Australian Perspective

Chen Han Yong,Anurag Gupta,Rohit Joshi

Translational Breast Cancer Research (2022): 36-36

引用0浏览0引用

564 Safety and clinical activities of the acid pH-sensitive anti-CTLA-4 mAb ONC-392 in ovarian cancer patients

John Hays,Tianhong Li,Hui Chen, George Zahrah, Richard Frank,John Hamm,Merry-Jennifer Markham,Thomas George,Eric Whitman,Mark Goldstein,Kai He,Rohit Joshi,Dan Chen,Yang Liu,Pan Zheng,David O'Malley

Regular and Young Investigator Award Abstracts (2022): A591-A591

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn